ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1110

Expanding Access to Research Using Tele-Health: Lupus and Informatics Feasibility Study

Trevor Faith1, Jihad Obeid 1, Kit Simpson 1 and Diane Kamen 2, 1Medical University of South Carolina, Charleston, 2Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Charleston, SC

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: clinical research methods and African-Americans, Systemic lupus erythematosus (SLE), Telehealth

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Health Services Research Poster II – ACR/ARP

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Participating in clinical research can be burdensome for subjects due to time and travel barriers, particularly among underserved, rural, and/or chronic disease bearing populations such as systemic lupus erythematosus (SLE). Telemedicine offers one way to overcome these barriers by providing tele-research visits. Doxy.me is a platform which facilitates these types of visits with its tele-consent functionality. However, diverging from the traditional in-person informed consent methodology could unduly influence subjects’ willingness to participate, reduce their comprehension of their study and associated risks or benefits. This poses an ethical concern that warrants exploration prior to widespread implementation. In this study, we examined the impact of tele-consent on measures of consent quality as compared to in-person consenting procedures. 

Methods: Assessments of perceived decision-making control (Decision Making Control Index, DMCI), consent quality (Quality of Informed Consent, QuIC), and health literacy (Short Assessment of Health Literacy – English Version) were integrated into an ongoing observational study. This study enrolls African American patients with SLE and healthy controls over the age of 18, many of whom are of Gullah Geechee heritage. Subjects were invited to participate in tele-consent and associated assessments at their in-person observational study visit. Willing subjects were randomized to tele-consent or standard in-person consent, followed by consent assessments. An independent samples t-test was used to compare mean outcome scores and age, whereas the chi-squared test was used for categorical demographic variables.

Results: Twenty-five subjects have completed the study, 12 of whom were randomized to tele-consent. There were no significant differences in age (mean 49 ± 15.39), sex (96% female), or health literacy scores (mean 16.7 ± 2.14, out of 18). The study sample is entirely African American, possesses health insurance, and 52% are diagnosed with SLE. Two tele-consent subjects were unable to complete their tele-consent encounters. One failure was due to a software issue while the other failed due to subject usability problems. Outcome measures did not vary significantly between groups; for tele-consent and standard consent the QuIC part A scores were 95.0 and 92.9 respectively (p = 6.83) out of 100, whereas the Part B scores were 4.9 and 4.8 respectively (p = 0.851) out of 5. Similarly, scores on the DMCI were 51.2 and 50.8 (p = 0.974) out of 54. 

Conclusion: The lack of statistically significant differences in outcome measures is promising for the validity of tele-consent. However, two tele-consent failures, one of which was due to the software, were encountered. A larger sample size will provide greater surety in these results and determine if failures may be a significant barrier to implementation. Tele-consenting is a novel methodology to increase recruitment and retention of under-served and hard to reach populations in minimally invasive studies. Trials may benefit from partnering with external laboratories or satellite clinics to facilitate more complex research visits while maintaining a reduction in travel burden for participants.


Disclosure: T. Faith, None; J. Obeid, None; K. Simpson, None; D. Kamen, None.

To cite this abstract in AMA style:

Faith T, Obeid J, Simpson K, Kamen D. Expanding Access to Research Using Tele-Health: Lupus and Informatics Feasibility Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/expanding-access-to-research-using-tele-health-lupus-and-informatics-feasibility-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expanding-access-to-research-using-tele-health-lupus-and-informatics-feasibility-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology